SCHEMBL29139947

SCHEMBL29139947

C=C(C)c1ccccc1[C@@H]1CCCN1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ CHRM5 P08912 5/20 0.39
▸ CHRM3 P20309 5/20 0.39
▸ CHRM2 P08172 5/20 0.39
▸ CHRM1 P11229 4/20 0.39
▸ CHRM4 P08173 4/20 0.39
▸ TAAR1 Q96RJ0 2/20 0.38
▸ CHRNB2 P17787 1/20 0.38
▸ CHRNA7 P36544 1/20 0.38
▸ CHRNA4 P43681 1/20 0.38
▸ PARP1 P09874 2/20 0.36
▸ DRD2 P14416 1/20 0.36
▸ PDCD1LG2 Q9BQ51 1/20 0.36
▸ CD274 Q9NZQ7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23323103 1.00 MEN1 (0.40) MEN1KMT2ACHRM5CHRM3CHRM2
SCHEMBL24073689 0.84 PARP1 (0.42) MEN1KMT2ACHRM5CHRM3CHRM2
SCHEMBL818385 0.81 ADRA2A (0.33) MEN1KMT2ACHRNB2CHRNA4
SCHEMBL28789929 0.79 PARP1 (0.43) MEN1KMT2ACHRM5CHRM3CHRM2
SCHEMBL28452039 0.79 PARP1 (0.43) MEN1KMT2ACHRM5CHRM3CHRM2
Hydrochloric Acid SCHEMBL27912312 0.78 MEN1 (0.39) MEN1KMT2APARP1
SCHEMBL28965493 0.77 PARP1 (0.42) MEN1KMT2ACHRM5CHRM3CHRM2
SCHEMBL28944768 0.77 PARP1 (0.54) PARP1
SCHEMBL27823213 0.77 PARP1 (0.54) PARP1
SCHEMBL23323171 0.77 CREBBP (0.51) MEN1KMT2APARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117683029-A Bcl-2 inhibitors 百济神州有限公司 2024-03-12 — — CN disclosed
CN-117430601-A Bcl-2 inhibitors 百济神州有限公司 2024-01-23 — — CN disclosed
CN-112437772-B Bcl-2 inhibitors 百济神州有限公司 2023-11-21 — — CN disclosed
WO-2022140224-A1 1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES AS BCL-2 INHIBITORS FOR THE TREATMENT OF NEOPLASTIC AND AUTOIMMUNE DISEASES NEWAVE PHARMACEUTICAL INC. (US) 2022-06-30 — — WO disclosed
Send feedback